PMVK
Phosphomevalonate kinase
Also known as: HUMPMKI, PMK, PMKA, PMVK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q15126
- Gene
- PMVK
- Ensembl
- ENSG00000163344
- Chromosome
- 1
- Canonical length
- 192 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a peroxisomal enzyme that is a member of the galactokinase, homoserine kinase, mevalonate kinase, and phosphomevalonate kinase (GHMP) family of ATP-dependent enzymes. The encoded protein catalyzes the conversion of mevalonate 5-phosphate to mevalonate 5-diphosphate, which is the fifth step in the mevalonate pathway of isoprenoid biosynthesis. Mutations in this gene are linked to certain types of porokeratosis including disseminated superficial porokeratosis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2017]
Canonical amino-acid sequenceUniProt
192 residues, UniProt reviewed canonical sequence.
>Q15126|PMVK
1 MAPLGGAPRL VLLFSGKRKS GKDFVTEALQ SRLGADVCAV LRLSGPLKEQ YAQEHGLNFQ
61 RLLDTSTYKE AFRKDMIRWG EEKRQADPGF FCRKIVEGIS QPIWLVSDTR RVSDIQWFRE
121 AYGAVTQTVR VVALEQSRQQ RGWVFTPGVD DAESECGLDN FGDFDWVIEN HGVEQRLEEQ
181 LENLIEFIRS RLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PMVK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 111 nTPM
Expression across tissuesHPA
Tissue
- liver: 111 nTPM
- basal ganglia: 104 nTPM
- choroid plexus: 100 nTPM
- cerebral cortex: 97 nTPM
- amygdala: 91 nTPM
- esophagus: 89 nTPM
Single-cell type
- esophageal suprabasal cells: 433 nCPM
- esophageal apical cells: 416 nCPM
- cytotrophoblasts: 294 nCPM
- syncytiotrophoblasts: 290 nCPM
- esophageal basal cells: 219 nCPM
- enterocytes: 218 nCPM
Immune cell
- non-classical monocyte: 221 nTPM
- intermediate monocyte: 206 nTPM
- T-reg: 135 nTPM
- memory B-cell: 115 nTPM
- naive B-cell: 112 nTPM
- MAIT T-cell: 110 nTPM
Brain region
- thalamus: 61 nTPM
- basal ganglia: 54 nTPM
- white matter: 53 nTPM
- amygdala: 53 nTPM
- medulla oblongata: 51 nTPM
- cerebellum: 50 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PMVK.
Disease | AllUniProt
Conditions PMVK is implicated in, by any mechanism.
- Porokeratosis 1, multiple types (POROK1) MIM:175800
Disease | GeneticClinVar
6 pathogenic / likely-pathogenic of 58 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Porokeratosis 1, Mibelli type
- Linear porokeratosis
- PMVK-related disorder
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.4
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.75
- DepMap mean gene effect
- -0.29
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cholesterol biosynthetic process
- isopentenyl diphosphate biosynthetic process, mevalonate pathway
- response to cholesterol
- sterol biosynthetic process
Molecular functions
- ATP binding
- phosphomevalonate kinase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- P-loop containing nucleoside triphosphate hydrolase
- Higher eukaryotic phosphomevalonate kinase
- Phosphomevalonate kinase
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PMVK as an antibody target. Whether an autoantibody or antibody against PMVK could matter depends on whether native PMVK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PMVK is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label PMVK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...